DETAILS, FICTION AND E7449

Attainable predictive biomarkers for tumor response to mTOR inhibitors, as have already been explained in glioblastoma, breast and prostate most cancers cells, will be the differential expression of mTOR pathway proteins, PTEN, AKT, and S6.[1] As a result, this details is predicated on preclinical assays, depending on in vitro cultured tumor mobile